Dr. Nadeau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3577 W 13 Mile Rd
Ste 103
Royal Oak, MI 48073Phone+1 248-288-4500Fax+1 248-288-0450
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1999 - 2002
- Case Western Reserve University School of MedicineClass of 1999
Certifications & Licensure
- MI State Medical License 2005 - 2027
- OH State Medical License 1999 - 2006
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
- Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence Start of enrollment: 2011 Nov 01
Publications & Presentations
PubMed
- 97 citationsKinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplanta...Nashaat S. Hamza, Michelle V. Lisgaris, Gopala K. Yadavalli, Laura Nadeau, Robert J. Fox
British Journal of Haematology. 2004-02-01 - 45 citationsDose–Volume Analysis of Predictors for Gastrointestinal Toxicity After Concurrent Full-Dose Gemcitabine and Radiotherapy for Locally Advanced Pancreatic AdenocarcinomaJiayi Huang, John M. Robertson, Hong Ye, J. Margolis, Laura Nadeau
International Journal of Radiation Oncology, Biology, Physics. 2012-07-15 - 5 citationsImplementing a Multidisciplinary Open-Access Clinic at a Private Practice–Based Community HospitalRobert P. Jury, Laura Nadeau, Harry Wasvary, Rebecca Levine, John M. Robertson
Journal of Oncology Practice. 2010-11-01
Press Mentions
- Phase 2 Study of Duvelisib in Previously Treated Patients with Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (BRIO)December 12th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: